In contrast, adult ALL is enriched in high-risk genetic subtypes (e.g., BCR-ABL1 or KMT2A rearrangements) and somatic mutations (e.g., TP53), which drive chemoresistance and relapse (28, 32). The gene discussed is TP53; the disease is acute lymphoblastic leukemia.